Mechanisms of Tolerance and Resistance to Chlorhexidine in Clinical Strains of <i>Klebsiella pneumoniae</i> Producers of Carbapenemase: Role of New Type II Toxin-Antitoxin System, PemIK
Although the failure of antibiotic treatment is normally attributed to resistance, tolerance and persistence display a significant role in the lack of response to antibiotics. Due to the fact that several nosocomial pathogens show a high level of tolerance and/or resistance to chlorhexidine, in this...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Toxins |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6651/12/9/566 |
id |
doaj-929848321bb34a72ab437a42b9d34a7b |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ines Bleriot Lucia Blasco Mercedes Delgado-Valverde Ana Gual de Torella Anton Ambroa Laura Fernandez-Garcia Maria Lopez Jesus Oteo-Iglesias Thomas K. Wood Alvaro Pascual German Bou Felipe Fernandez-Cuenca Maria Tomas |
spellingShingle |
Ines Bleriot Lucia Blasco Mercedes Delgado-Valverde Ana Gual de Torella Anton Ambroa Laura Fernandez-Garcia Maria Lopez Jesus Oteo-Iglesias Thomas K. Wood Alvaro Pascual German Bou Felipe Fernandez-Cuenca Maria Tomas Mechanisms of Tolerance and Resistance to Chlorhexidine in Clinical Strains of <i>Klebsiella pneumoniae</i> Producers of Carbapenemase: Role of New Type II Toxin-Antitoxin System, PemIK Toxins tolerance persistence cross-resistance toxin-antitoxin system PemI/PemK <i>Klebsiella pneumoniae</i> |
author_facet |
Ines Bleriot Lucia Blasco Mercedes Delgado-Valverde Ana Gual de Torella Anton Ambroa Laura Fernandez-Garcia Maria Lopez Jesus Oteo-Iglesias Thomas K. Wood Alvaro Pascual German Bou Felipe Fernandez-Cuenca Maria Tomas |
author_sort |
Ines Bleriot |
title |
Mechanisms of Tolerance and Resistance to Chlorhexidine in Clinical Strains of <i>Klebsiella pneumoniae</i> Producers of Carbapenemase: Role of New Type II Toxin-Antitoxin System, PemIK |
title_short |
Mechanisms of Tolerance and Resistance to Chlorhexidine in Clinical Strains of <i>Klebsiella pneumoniae</i> Producers of Carbapenemase: Role of New Type II Toxin-Antitoxin System, PemIK |
title_full |
Mechanisms of Tolerance and Resistance to Chlorhexidine in Clinical Strains of <i>Klebsiella pneumoniae</i> Producers of Carbapenemase: Role of New Type II Toxin-Antitoxin System, PemIK |
title_fullStr |
Mechanisms of Tolerance and Resistance to Chlorhexidine in Clinical Strains of <i>Klebsiella pneumoniae</i> Producers of Carbapenemase: Role of New Type II Toxin-Antitoxin System, PemIK |
title_full_unstemmed |
Mechanisms of Tolerance and Resistance to Chlorhexidine in Clinical Strains of <i>Klebsiella pneumoniae</i> Producers of Carbapenemase: Role of New Type II Toxin-Antitoxin System, PemIK |
title_sort |
mechanisms of tolerance and resistance to chlorhexidine in clinical strains of <i>klebsiella pneumoniae</i> producers of carbapenemase: role of new type ii toxin-antitoxin system, pemik |
publisher |
MDPI AG |
series |
Toxins |
issn |
2072-6651 |
publishDate |
2020-09-01 |
description |
Although the failure of antibiotic treatment is normally attributed to resistance, tolerance and persistence display a significant role in the lack of response to antibiotics. Due to the fact that several nosocomial pathogens show a high level of tolerance and/or resistance to chlorhexidine, in this study we analyzed the molecular mechanisms associated with chlorhexidine adaptation in two clinical strains of <i>Klebsiella pneumoniae</i> by phenotypic and transcriptomic studies. These two strains belong to ST258-KPC3 (high-risk clone carrying β-lactamase KPC3) and ST846-OXA48 (low-risk clone carrying β-lactamase OXA48). Our results showed that the <i>K. pneumoniae</i> ST258-KPC3CA and ST846-OXA48CA strains exhibited a different behavior under chlorhexidine (CHLX) pressure, adapting to this biocide through resistance and tolerance mechanisms, respectively. Furthermore, the appearance of cross-resistance to colistin was observed in the ST846-OXA48CA strain (tolerant to CHLX), using the broth microdilution method. Interestingly, this ST846-OXA48CA isolate contained a plasmid that encodes a novel type II toxin/antitoxin (TA) system, PemI/PemK. We characterized this PemI/PemK TA system by cloning both genes into the IPTG-inducible pCA24N plasmid, and found their role in persistence and biofilm formation. Accordingly, the ST846-OXA48CA strain showed a persistence biphasic curve in the presence of a chlorhexidine-imipenem combination, and these results were confirmed by the enzymatic assay (WST-1). |
topic |
tolerance persistence cross-resistance toxin-antitoxin system PemI/PemK <i>Klebsiella pneumoniae</i> |
url |
https://www.mdpi.com/2072-6651/12/9/566 |
work_keys_str_mv |
AT inesbleriot mechanismsoftoleranceandresistancetochlorhexidineinclinicalstrainsofiklebsiellapneumoniaeiproducersofcarbapenemaseroleofnewtypeiitoxinantitoxinsystempemik AT luciablasco mechanismsoftoleranceandresistancetochlorhexidineinclinicalstrainsofiklebsiellapneumoniaeiproducersofcarbapenemaseroleofnewtypeiitoxinantitoxinsystempemik AT mercedesdelgadovalverde mechanismsoftoleranceandresistancetochlorhexidineinclinicalstrainsofiklebsiellapneumoniaeiproducersofcarbapenemaseroleofnewtypeiitoxinantitoxinsystempemik AT anagualdetorella mechanismsoftoleranceandresistancetochlorhexidineinclinicalstrainsofiklebsiellapneumoniaeiproducersofcarbapenemaseroleofnewtypeiitoxinantitoxinsystempemik AT antonambroa mechanismsoftoleranceandresistancetochlorhexidineinclinicalstrainsofiklebsiellapneumoniaeiproducersofcarbapenemaseroleofnewtypeiitoxinantitoxinsystempemik AT laurafernandezgarcia mechanismsoftoleranceandresistancetochlorhexidineinclinicalstrainsofiklebsiellapneumoniaeiproducersofcarbapenemaseroleofnewtypeiitoxinantitoxinsystempemik AT marialopez mechanismsoftoleranceandresistancetochlorhexidineinclinicalstrainsofiklebsiellapneumoniaeiproducersofcarbapenemaseroleofnewtypeiitoxinantitoxinsystempemik AT jesusoteoiglesias mechanismsoftoleranceandresistancetochlorhexidineinclinicalstrainsofiklebsiellapneumoniaeiproducersofcarbapenemaseroleofnewtypeiitoxinantitoxinsystempemik AT thomaskwood mechanismsoftoleranceandresistancetochlorhexidineinclinicalstrainsofiklebsiellapneumoniaeiproducersofcarbapenemaseroleofnewtypeiitoxinantitoxinsystempemik AT alvaropascual mechanismsoftoleranceandresistancetochlorhexidineinclinicalstrainsofiklebsiellapneumoniaeiproducersofcarbapenemaseroleofnewtypeiitoxinantitoxinsystempemik AT germanbou mechanismsoftoleranceandresistancetochlorhexidineinclinicalstrainsofiklebsiellapneumoniaeiproducersofcarbapenemaseroleofnewtypeiitoxinantitoxinsystempemik AT felipefernandezcuenca mechanismsoftoleranceandresistancetochlorhexidineinclinicalstrainsofiklebsiellapneumoniaeiproducersofcarbapenemaseroleofnewtypeiitoxinantitoxinsystempemik AT mariatomas mechanismsoftoleranceandresistancetochlorhexidineinclinicalstrainsofiklebsiellapneumoniaeiproducersofcarbapenemaseroleofnewtypeiitoxinantitoxinsystempemik |
_version_ |
1724449890993438720 |
spelling |
doaj-929848321bb34a72ab437a42b9d34a7b2020-11-25T04:00:33ZengMDPI AGToxins2072-66512020-09-011256656610.3390/toxins12090566Mechanisms of Tolerance and Resistance to Chlorhexidine in Clinical Strains of <i>Klebsiella pneumoniae</i> Producers of Carbapenemase: Role of New Type II Toxin-Antitoxin System, PemIKInes Bleriot0Lucia Blasco1Mercedes Delgado-Valverde2Ana Gual de Torella3Anton Ambroa4Laura Fernandez-Garcia5Maria Lopez6Jesus Oteo-Iglesias7Thomas K. Wood8Alvaro Pascual9German Bou10Felipe Fernandez-Cuenca11Maria Tomas12Microbiology Department-Research Institute Biomedical A Coruña (INIBIC), Hospital A Coruña (CHUAC), University of A Coruña (UDC), 15006 A Coruña, SpainMicrobiology Department-Research Institute Biomedical A Coruña (INIBIC), Hospital A Coruña (CHUAC), University of A Coruña (UDC), 15006 A Coruña, SpainClinical Unit for Infectious Diseases, Department of Microbiology and Medicine, Microbiology and Preventive Medicine, Hospital Universitario Virgen Macarena, University of Seville, Biomedicine Insititute of Seville (IBIS), 41009 Seville, SpainClinical Unit for Infectious Diseases, Department of Microbiology and Medicine, Microbiology and Preventive Medicine, Hospital Universitario Virgen Macarena, University of Seville, Biomedicine Insititute of Seville (IBIS), 41009 Seville, SpainMicrobiology Department-Research Institute Biomedical A Coruña (INIBIC), Hospital A Coruña (CHUAC), University of A Coruña (UDC), 15006 A Coruña, SpainMicrobiology Department-Research Institute Biomedical A Coruña (INIBIC), Hospital A Coruña (CHUAC), University of A Coruña (UDC), 15006 A Coruña, SpainMicrobiology Department-Research Institute Biomedical A Coruña (INIBIC), Hospital A Coruña (CHUAC), University of A Coruña (UDC), 15006 A Coruña, SpainStudy Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) the Behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), 28003 Madrid, SpainDepartment of Chemical Engineering, Pennsylvania State University, University Park, PA 16801, USAStudy Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) the Behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), 28003 Madrid, SpainMicrobiology Department-Research Institute Biomedical A Coruña (INIBIC), Hospital A Coruña (CHUAC), University of A Coruña (UDC), 15006 A Coruña, SpainStudy Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) the Behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), 28003 Madrid, SpainMicrobiology Department-Research Institute Biomedical A Coruña (INIBIC), Hospital A Coruña (CHUAC), University of A Coruña (UDC), 15006 A Coruña, SpainAlthough the failure of antibiotic treatment is normally attributed to resistance, tolerance and persistence display a significant role in the lack of response to antibiotics. Due to the fact that several nosocomial pathogens show a high level of tolerance and/or resistance to chlorhexidine, in this study we analyzed the molecular mechanisms associated with chlorhexidine adaptation in two clinical strains of <i>Klebsiella pneumoniae</i> by phenotypic and transcriptomic studies. These two strains belong to ST258-KPC3 (high-risk clone carrying β-lactamase KPC3) and ST846-OXA48 (low-risk clone carrying β-lactamase OXA48). Our results showed that the <i>K. pneumoniae</i> ST258-KPC3CA and ST846-OXA48CA strains exhibited a different behavior under chlorhexidine (CHLX) pressure, adapting to this biocide through resistance and tolerance mechanisms, respectively. Furthermore, the appearance of cross-resistance to colistin was observed in the ST846-OXA48CA strain (tolerant to CHLX), using the broth microdilution method. Interestingly, this ST846-OXA48CA isolate contained a plasmid that encodes a novel type II toxin/antitoxin (TA) system, PemI/PemK. We characterized this PemI/PemK TA system by cloning both genes into the IPTG-inducible pCA24N plasmid, and found their role in persistence and biofilm formation. Accordingly, the ST846-OXA48CA strain showed a persistence biphasic curve in the presence of a chlorhexidine-imipenem combination, and these results were confirmed by the enzymatic assay (WST-1).https://www.mdpi.com/2072-6651/12/9/566tolerancepersistencecross-resistancetoxin-antitoxin systemPemI/PemK<i>Klebsiella pneumoniae</i> |